Showing results (21-30 of 13,207) with videos related to

Sort By:
Pageof 1,321
Advances in Experimental Medicine and Biology|September 13, 2011
Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathyXian-Cheng Jiang, Ira J Goldberg, Tae-Sik Park
Arteriosclerosis, Thrombosis, and Vascular Biology|July 13, 2013
Liver-specific phospholipid transfer protein deficiency reduces high-density lipoprotein and non-high-density lipoprotein production in miceAmirfarbod Yazdanyar, Wei Quan, Weijun Jin, et al.
Frontiers in Cardiovascular Medicine|February 2, 2019
Macrophage Lysophosphatidylcholine Acyltransferase 3 Deficiency-Mediated Inflammation Is Not Sufficient to Induce Atherosclerosis in a Mouse ModelHui Jiang, Zhiqiang Li, Chongmin Huan, et al.
International Journal of Biological Macromolecules|February 25, 2026
In situ delipidation-based structure of low-density lipoprotein and apolipoprotein B-100 physiologically imaged by atomic force microscopyKun Wang, Ying Qin, Xian-Cheng Jiang, et al.
Journal of Lipid Research|November 22, 2008
The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesisDavid Masson, Xian-Cheng Jiang, Laurent Lagrost, et al.
Drug News & Perspectives|March 3, 2004
Liver X receptors as potential therapeutic targets for multiple diseasesGuoqing Cao, Yu Liang, Xian-Cheng Jiang, et al.
Journal of Lipid Research|February 3, 2004
A simple, rapid, and sensitive fluorescence assay for microsomal triglyceride transfer proteinHumra Athar, Jahangir Iqbal, Xian-Cheng Jiang, et al.
Nutrition & Metabolism|December 16, 2011
Subcellular targeting domains of sphingomyelin synthase 1 and 2Calvin Yeang, Tingbo Ding, William J Chirico, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2012
Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in miceZhiqiang Li, Yifan Fan, Jing Liu, et al.
Pageof 1,321